Dover Advisors LLC acquired a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,863 shares of the financial services provider's stock, valued at approximately $789,000.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Great Lakes Advisors LLC boosted its position in shares of CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider's stock worth $441,000 after buying an additional 37 shares during the period. SeaCrest Wealth Management LLC raised its stake in shares of CME Group by 3.0% in the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after acquiring an additional 40 shares in the last quarter. OneAscent Financial Services LLC raised its stake in shares of CME Group by 4.0% in the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock valued at $293,000 after acquiring an additional 43 shares in the last quarter. Ballentine Partners LLC raised its stake in shares of CME Group by 0.8% in the first quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock valued at $1,546,000 after acquiring an additional 45 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC raised its stake in CME Group by 3.6% in the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after buying an additional 47 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of analysts have weighed in on the company. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Barclays set a $298.00 price target on CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Finally, Citigroup raised their price objective on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, CME Group has an average rating of "Hold" and an average target price of $260.60.
View Our Latest Stock Report on CME Group
CME Group Price Performance
Shares of CME opened at $262.30 on Monday. CME Group Inc. has a twelve month low of $212.38 and a twelve month high of $290.79. The stock's 50 day moving average is $273.60 and its two-hundred day moving average is $270.59. The firm has a market capitalization of $94.53 billion, a PE ratio of 25.39, a P/E/G ratio of 4.75 and a beta of 0.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the firm earned $2.56 EPS. The company's revenue for the quarter was up 10.4% on a year-over-year basis. Research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's payout ratio is 48.40%.
Insider Buying and Selling at CME Group
In related news, Director William R. Shepard acquired 256 shares of the stock in a transaction dated Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director directly owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares of the company's stock, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.